Marina Biotech

LifeTech Capital is out with its report on Marina Biotech (NASDAQ: MRNA), after initiating MRNA at Strong Speculative Buy. In a note to clients, LifeTech Capital writes, "We believe that Marina Biotech represents one of the potential winners in the relatively new and fragmented RNAi space. In our...